Purple Biotech Ltd banner
P

Purple Biotech Ltd
TASE:PPBT

Watchlist Manager
Purple Biotech Ltd
TASE:PPBT
Watchlist
Price: 1 ILS Market Closed
Market Cap: ₪17.8m

Purple Biotech Ltd
Investor Relations

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Gil Efron CPA, M.A.
Chief Executive Officer
No Bio Available
Dr. Michael Schickler Ph.D.
Head of Clinical & Regulatory Affairs
No Bio Available
Mr. Ido Morpurgo B.Sc., L.L.M.
Vice President of Operations
No Bio Available

Contacts

Address
Rehovot
Oppenheimer 4
Contacts
+97239333121.0
purple-biotech.com